Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Exxon Mobil
XOM
|
$2.48B |
| 2 |
Wells Fargo
WFC
|
$2.4B |
| 3 |
NVIDIA
NVDA
|
$2.03B |
| 4 |
American Express
AXP
|
$948M |
| 5 |
Amazon
AMZN
|
$855M |
Top Sells
| 1 |
Pfizer
PFE
|
$1.71B |
| 2 |
Chubb
CB
|
$1.57B |
| 3 |
ConocoPhillips
COP
|
$1.49B |
| 4 |
Microsoft
MSFT
|
$1.37B |
| 5 |
Advanced Micro Devices
AMD
|
$1.15B |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Healthcare | 20.37% |
| 3 | Financials | 14.37% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Graham Holdings Company
GHC
$4.93B
| $720K | ﹤0.01% |
938
| – | – |
|
1652
Boston Properties
BXP
$12.2B
| $717K | ﹤0.01% |
10,977
+643
| +6% | +$42K |
|
1653
OP Bancorp
OPBK
$212M
| $713K | ﹤0.01% |
71,486
-686
| -1% | -$6.85K |
|
1654
Gildan
GIL
$8.27B
| $710K | ﹤0.01% |
19,104
-1,550
| -8% | -$57.6K |
|
1655
Paycom
PAYC
$12.6B
| $709K | ﹤0.01% |
3,562
+269
| +8% | +$53.5K |
|
1656
Broadridge
BR
$29.4B
| $707K | ﹤0.01% |
3,450
+1,166
| +51% | +$239K |
|
1657
Lineage Cell Therapeutics
LCTX
$279M
| $692K | ﹤0.01% |
+467,545
| New | +$692K |
|
1658
Polaris
PII
$3.33B
| $690K | ﹤0.01% |
6,887
+765
| +12% | +$76.6K |
|
1659
Southern California Bancorp
BCAL
$556M
| $685K | ﹤0.01% |
45,963
+2,599
| +6% | +$38.8K |
|
1660
Charles River Laboratories
CRL
$8.07B
| $684K | ﹤0.01% |
2,523
-193
| -7% | -$52.3K |
|
1661
Pegasystems
PEGA
$9.5B
| $680K | ﹤0.01% |
+21,052
| New | +$680K |
|
1662
Ovid Therapeutics
OVID
$87.5M
| $680K | ﹤0.01% |
+222,893
| New | +$680K |
|
|
MTAL.WS
1663
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
| $674K | ﹤0.01% |
330,300
| – | – |
|
|
JNPR
1664
DELISTED
Juniper Networks
JNPR
| $667K | ﹤0.01% |
18,008
-16,815
| -48% | -$623K |
|
1665
Consolidated Edison
ED
$35.4B
| $648K | ﹤0.01% |
7,134
-641
| -8% | -$58.2K |
|
1666
Check Point Software Technologies
CHKP
$20.7B
| $643K | ﹤0.01% |
3,919
+462
| +13% | +$75.8K |
|
1667
Compass Therapeutics
CMPX
$590M
| $635K | ﹤0.01% |
+320,621
| New | +$635K |
|
1668
Revvity
RVTY
$10.1B
| $634K | ﹤0.01% |
6,035
-479
| -7% | -$50.3K |
|
1669
Omeros
OMER
$284M
| $617K | ﹤0.01% |
+178,818
| New | +$617K |
|
1670
Humacyte
HUMA
$226M
| $616K | ﹤0.01% |
+198,064
| New | +$616K |
|
1671
Descartes Systems
DSGX
$9.26B
| $615K | ﹤0.01% |
6,721
+349
| +5% | +$32K |
|
1672
HF Sinclair
DINO
$9.56B
| $614K | ﹤0.01% |
10,169
-247
| -2% | -$14.9K |
|
1673
SPDR S&P International Small Cap ETF
GWX
$773M
| $613K | ﹤0.01% |
18,879
-1,819
| -9% | -$59.1K |
|
1674
Maravai LifeSciences
MRVI
$363M
| $613K | ﹤0.01% |
70,658
| – | – |
|
|
DQ
1675
Daqo New Energy
DQ
$1.96B
| $612K | ﹤0.01% |
+21,753
| New | +$612K |
|